Saturday, August 18, 2018
 
 
Company News: Page (1) of 1 - 02/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Sage HMS and MedCurrent Announce Partnership for Enhancing Diagnostic Imaging Recommendations
 
(February 13, 2018)
Sage HMS and MedCurrent Announce Partnership for Enhancing Diagnostic Imaging Recommendations

Sage Health Management Solutions, Inc., (Sage HMS) a healthcare information technology company focused on prescriptive and predictive analytics, and MedCurrent announced a new partnership where Sage HMS will license its CMS Priority Clinical Areas content to be integrated into the MedCurrent OrderWise® Clinical Decision Support (CDS) solution.

Through the agreement, the integrated offering will further provide ordering clinicians with evidence based guidelines for selecting the most appropriate imaging for their patients, assuring that the right radiology exams are performed while reducing unnecessary tests. This also helps provide expanded data choices for ordering clinicians through the OrderWise® solution.

MedCurrent is now able to expand its qualified provider-led entity (PLE) data sources through this agreement to use Sage Evidence-based Medicine & Practice Institute (SEMPI), a CMS qualified PLE who has an exclusive license agreement with Sage HMS – adhering to the 2014 Protecting Access to Medicare Act (PAMA) where CDS providers can integrate data from multiple providers. The SEMPI content is also providing the full set of Medicare requirements for appropriate use criteria (AUC) as required under 414.94(b) and (c) Center for Medicare and Medicaid Services' (CMS) proposed rule for the priority clinical areas.



“The integration of the SEMPI content and data into our OrderWise solutions allows us to further guide referring clinicians through differential diagnoses and help them make the right imaging request for their patients," said John Adziovsky, CEO, MedCurrent. “Ultimately, this partnership helps physicians to access more evidence-based decision support, which will enhance care quality and outcomes."

“This partnership is a prime example of how a CDS solution can now take full advantage of integrating evidence-based guideline data from multiple sources, which is now possible under PAMA," said said Dr. Katherine Gray, President, Sage HMS.

SEMPI improves the field of knowledge in Evidence-based Medicine for clinical practice by understanding how scientific studies can be applied in clinical practice and where practice will benefit from more research..

About MedCurrent
MedCurrent is a physician-founded Clinical Decision Support (CDS) company focused on improving the quality of care and managing health system costs through our innovative and scalable solution, OrderWise®. Our solution enhances the clinical decision-making process with real-time, evidence-based guidelines integrated at the point of care to improve health and healthcare delivery. Deep healthcare experience, superior technology and business agility make MedCurrent a global leader in CDS solutions. More information about MedCurrent is available here.
About Sage HMS
Sage Health Management Solutions, Inc. (Sage HMS), a DSS Inc. company, is a healthcare information technology company focused on prescriptive and predictive analytics. Sage HMS tools, specifically RadWise® imaging qualified CDSM provides the most robust imaging clinical content and most user-friendly interface strategies to meet each customer's needs, including stand-alone web portal and integrated EHR options with web services.

Read the full story at http://www.prweb.com/releases/2018/02/prweb15199608.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   itbusinessnet.com ,   IBN - Business ,   IBN - Internet ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines